Smart for Life Releases Video Showcasing New High Protein Ice Cream

3 years ago

Dr. Sasson Moulavi Discusses Benefits of Smart for Life’s Unique New Product CategoryMIAMI, April 26, 2023 (GLOBE NEWSWIRE) -- Smart…

AUM Biosciences to Participate in Inaugural EF Hutton Global Conference

3 years ago

SINGAPORE and BETHESDA, Md., April 26, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotechnology company…

ContraFect Announces First Patient Dosed in the Phase 1b/2 Study of Exebacase in Patients with Chronic Prosthetic Joint Infections of the Knee

3 years ago

YONKERS, N.Y., April 26, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery…

Allied Corp Signs Joint Venture With Blueberries Medical Corp. to Expand Product Offering and Bring Derivative Products to Global Markets

3 years ago

KELOWNA, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID), a leading cannabis…

T2 Biosystems Highlights New Clinical Data Presented at the ECCMID 2023 Conference

3 years ago

LEXINGTON, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens…

Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023

3 years ago

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed…

Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023

3 years ago

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine…

OMNIMED Announces Appointment of Hugh Dodson to Dual Role of Chief Financial Officer & Chief Operating Officer

3 years ago

Dodson to provide strategic guidance to secure new revenue streams, grow presence in value-based healthcare environment Hugh Dodson - CFO…

SAB Biotherapeutics Announces Positive Results from Phase 3 Trial of SAB-185 in Patients with COVID-19 at High-Risk for Severe Complications

3 years ago

SAB-185, a human IgG1 (polyclonal) antibody therapeutic candidate, demonstrated benefit in sustained symptom resolution in patients with Omicron variants of…

Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ

3 years ago

BOSTON, April 26, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based…